Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the global size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 11.20% during the review period (2022 to 2027)
A breast biopsy is a procedure that is generally done after ultrasound or mammography only when a suspicious lesion or hard palpable lump is discovered in any of the mentioned tests. A breast biopsy needle removes a sample of the suspicious tissue which is then sent to pathologists to analyze. Palpable lumps or abnormalities can be found with the help of physical examination, self-examination or mammography though it is not possible with these tests to tell whether the abnormal growth is cancerous or benign. Breast biopsy is not an initial procedure as it is recommended by doctors after identifying a lump of thickening of the breast or if the mammogram finds a suspicious tissue in the breast.
The operator or the physician might move the needle around the suspicious area in order to collect the sample and may collect around 8 samples from different parts of the body. There are several types of biopsy procedures, most of those being minimally invasive which along with rising cases of breast cancer across the world is driving the market.Breast Biopsy Needle Market highlights the potential growth opportunities in upcoming years, while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects in the global market. The Global Breast Biopsy Needle Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. This Research Study compares the markets of Pre COVID-19 and Post COVID-19 with the impact of COVID-19 on the regional economy.
Top Key players in the Breast Biopsy Needle Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Breast Biopsy Needle Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes Ethicon Endo Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC.
June 15, 2011: Ethicon Endo-Surgery, Inc. (EES) announces U.S. FDA 510(k) clearance and the launch of the first ever Advanced Energy Generator made to power both ultrasonic and advance bipolar technologies and designed for easy set set-up and use in the operating room.
05/10/2022: Hologic, Inc. (Nasdaq: HOLX) announced that the U.S. Food and Drug Administration (FDA) approved its Aptima CMV Quant assay to quantify the viral load of cytomegalovirus (CMV) in patients who have had solid organ or stem cell transplants. The test is the first to be introduced in the U.S. by Hologic for post-transplant pathogen detection and monitoring on Hologic’s fully automated Panther® system, and joins the existing portfolio of diagnostic and viral load testing for HIV-1, Hepatitis C and Hepatitis B.
July 15, 2013 - Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, recently expanded its extensive array of interventional and imaging solutions for breast health with the launch of the world's first 3D breast biopsy option. This technology was developed for the Company's Affirm upright breast biopsy guidance system, which is used in conjunction with the Selenia Dimensions 2D and 3D mammography systems.
Breast Biopsy Needle Market is segmented based on the type, applications, companies and regions.
By Type, Breast Biopsy Needle Market has been segmented into
By Application, Breast Biopsy Needle Market has been segmented into
North America is currently dominating the market share, accounting for over 42% in the year 2020. The region was diagnosed with over 62% of breast cancer cases in recent times. The advancing medical infrastructure and technology have augmented the overall growth of the market in the region. Moreover, the increasing awareness of identifying the palpable lumps in breasts, early identification, and self-examination have also impacted the Breast Biopsy Needle market growth.
Report Attributes | Report Details |
Forecast Period 2022 to 2028 CAGR | CAGR of 11.20% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | Ethicon Endo Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard, Inc. |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages |
96 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Breast Biopsy Needle Market is studied from 2022-to 2027.
Who are the prominent players in the Breast Biopsy Needle Market?
Ethicon Endo Surgery, Intact Medical Corporation, Galini SRL, Hologic Inc., Leica Biosystems Nussloch GmbH, C. R. Bard,
Which region held the largest share in the Breast Biopsy Needle Market?
United States, Europe, China, Japan, Southeast Asia, India and Rest of World
What are the significant types of Breast Biopsy Needle Market?
Needle Based Biopsy, Surgical Biopsy, Core Needle Biopsy (CNB), Fine Needle Aspiration Biopsy (FNAB), Vacuum-assisted Biopsy (VAB), Open Surgical Breast Biopsy Needle
What are the major end-use applications of Breast Biopsy Needle Market?
Hospital, Clinic, Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.